Nutrição e Esteatose hepática não alcoólica – Artigo 18

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease Abstract Non-alcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease. It is characterized by a wide spectrum of hepatic changes, which may progress to liver fibrosis and to cirrhosis. NAFLD is considered as the hepatic component of the metabolic syndrome but mechanisms underlying…

This content is for Associação Básica, Associação Completa e Renovação members only.
Log In Register